# A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH

> **NCT00296465** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 132 (actual)

## Conditions studied

- InFertility

## Interventions

- **DRUG:** Pulsatile gonadotropin-releasing hormone (GnRH)
- **DRUG:** Clomiphene Citrate
- **DRUG:** Placebo Pulsatile GnRH
- **DRUG:** Placebo Clomiphene Citrate

## Key facts

- **NCT ID:** NCT00296465
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2011-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00296465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00296465, "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00296465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*